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Effect of Exposure to Small Pharmaceutical Promotional Items on
Treatment Preferences
Abstract
Background: Policy discussions concerning pharmaceutical promotion often assume that small promotional
items are unlikely to influence prescribing behavior. Our experiment measures whether exposure to these
items results in more favorable attitudes toward marketed products and whether policies that restrict
pharmaceutical marketing mitigate this effect.
Methods: This is a randomized controlled experiment of 352 third- and fourth-year medical students at two
US medical schools with differing policies toward pharmaceutical marketing. Participants assigned to
treatment were exposed to small branded promotional items for Lipitor (atorvastatin) without knowledge that
the exposure was part of the study. We measured differences in implicit (ie, unconscious) attitudes toward
Lipitor and Zocor (simvastatin) in exposed and control groups with the Implicit Association Test (IAT). Self-
reported attitudes were also measured, and a follow-up survey was administered measuring attitudes toward
marketing.
Results: Fourth-year students at the University of Miami Miller School of Medicine exposed to Lipitor
promotional items had more favorable implicit attitudes about that brand-name drug compared to the control
group (IAT effect: 0.66 vs 0.47; P = .05), while the effect was reversed at the University of Pennsylvania
School of Medicine (IAT effect: 0.22 vs 0.52; P = .002) where restrictive policies are in place limiting
pharmaceutical marketing (interaction effect: P = .003). No significant effect was observed among third-year
students. On a “skepticism” scale, University of Miami students held more favorable attitudes toward
pharmaceutical marketing compared to University of Pennsylvania students (0.55 vs 0.42; P
Conclusions: Subtle exposure to small pharmaceutical promotional items influences implicit attitudes toward
marketed products among medical students. We observed a reversal of this effect in the setting of restrictive
policies and more negative school-level attitudes toward marketing.
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ORIGINAL INVESTIGATION
Effect of Exposure to Small Pharmaceutical
Promotional Items on Treatment Preferences
David Grande, MD, MPA; Dominick L. Frosch, PhD; Andrew W. Perkins, PhD; Barbara E. Kahn, PhD
Background: Policy discussions concerning pharma-
ceutical promotion often assume that small promo-
tional items are unlikely to influence prescribing behav-
ior. Our experiment measures whether exposure to these
items results in more favorable attitudes toward mar-
keted products and whether policies that restrict phar-
maceutical marketing mitigate this effect.
Methods: This is a randomized controlled experiment
of 352 third- and fourth-year medical students at two US
medical schools with differing policies toward pharma-
ceutical marketing. Participants assigned to treatment were
exposed to small branded promotional items for Lipitor
(atorvastatin) without knowledge that the exposure was
part of the study. We measured differences in implicit
(ie, unconscious) attitudes toward Lipitor and Zocor (sim-
vastatin) in exposed and control groups with the Im-
plicit Association Test (IAT). Self-reported attitudes were
also measured, and a follow-up survey was adminis-
tered measuring attitudes toward marketing.
Results: Fourth-year students at the University of Mi-
ami Miller School of Medicine exposed to Lipitor pro-
motional items had more favorable implicit attitudes about
that brand-name drug compared to the control group (IAT
effect: 0.66 vs 0.47; P=.05), while the effect was re-
versed at the University of Pennsylvania School of Medi-
cine (IAT effect: 0.22 vs 0.52; P=.002) where restrictive
policies are in place limiting pharmaceutical marketing
(interaction effect: P=.003). No significant effect was ob-
served among third-year students. On a “skepticism” scale,
University of Miami students held more favorable atti-
tudes toward pharmaceutical marketing compared to Uni-
versity of Pennsylvania students (0.55 vs 0.42; P .001)
but the results were similar to those of a previously pub-
lished national study (0.42 vs 0.43; P=.53).
Conclusions: Subtle exposure to small pharmaceutical
promotional items influences implicit attitudes toward
marketed products among medical students. We ob-
served a reversal of this effect in the setting of restrictive
policies and more negative school-level attitudes to-
ward marketing.
Arch Intern Med. 2009;169(9):887-893
D ISCUSSIONS ABOUT THE IN-fluence of pharmaceuti-cal promotion on physi-cians often focus on giftsand payments of rela-
tively large economic value. This focus is
also evident in ethics guidelines address-
ing pharmaceutical promotion among
many professional medical societies.1 The
underlying assumption is that smaller gifts
are unlikely to exert influence on prescrib-
ing decisions.
In contrast, a substantial body of mar-
keting and psychology literature sug-
gests that even trivial items can exert in-
fluence irrespective of economic value. For
example, adding a small gift such as per-
sonalized mailing labels to a solicitation
for donations has been shown to signifi-
cantly increase contributions.2 In phar-
maceutical promotion, small gifts are of-
ten tethered to branding efforts, as items
such as pens and coffee mugs display logos.
Aside from the intrinsic value of promo-
tional items, branded materials strengthen
brand awareness and build brand equity
through a variety of largely unconscious
but powerful mechanisms.3 Nonverbal in-
formation about the brand, such as sym-
bols or logos, is often more influential than
verbal cues.4 Stronger brands have a
memory encoding and storage advantage
over unknown brands,5 which facilitates
the formation of strong positive associa-
tions with the brand. Strong branded prod-
ucts are more often in a “top-of-mind”
set of alternatives for consumers to con-
sider.6 Strong brand awareness provides a
justifiable reason for choosing a particu-
lar brand.7,8 This research suggests that
small branded promotional items should
increase favorable attitudes for the brand
being promoted. We are unaware of stud-
ies that test these effects in a clinical con-
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text with health professionals, but many physicians, be-
cause they are medical experts, believe they are not
susceptible to these influences.5,9,10 In one survey, just
8% of physicians believed they were susceptible to in-
fluence by marketing items such as branded pens, whereas
31% of patients felt these items could influence physi-
cians.9 The guidelines of the American Medical Associa-
tion regarding gifts to physicians from industry reflect
this belief of lack of susceptibility by permitting “gifts of
minimal value.”1
We used the Implicit Association Test (IAT)11 to mea-
sure the effect of simple exposure to small, branded pro-
motional items in the environment on treatment prefer-
ences of medical students. The IAT, described in greater
detail below, is an experimental approach designed to un-
cover otherwise unconscious or hidden attitudes. We stud-
ied medical students from 2 schools with differing poli-
cies toward pharmaceutical marketing (more restrictive
vs less restrictive) to test possible effect modification. We
hypothesized that medical students exposed to branded
promotional items would have more favorable attitudes
toward the branded product through the priming of posi-
tive associations. However, we hypothesized that the pres-
ence of a university policy restricting pharmaceutical mar-
keting would mitigate the positive associations with the
branded product due to the increased awareness of per-
suasive marketing tactics that such a policy may evoke.
METHODS
SETTING AND PARTICIPANTS
The study used a randomized experimental design. Partici-
pants were third- and fourth-year medical students at the Uni-
versity of Pennsylvania School of Medicine (Penn) and the Uni-
versity of Miami Miller School of Medicine (Miami). We selected
these institutions because of their differing policies regarding
interactions between trainees and pharmaceutical company rep-
resentatives. The University of Pennsylvania has restrictive poli-
cies in place that prohibit most gifts, meals, and samples while
Miami continues to permit such marketing practices.
Subjects were recruited by e-mail and flyers and were paid
$25 per person to participate in the study. Enrollment took place
between August 24, 2007, and April 4, 2008. The study was
approved by the Institutional Review Boards at the University
of Pennsylvania and the University of Miami.
EXPERIMENTAL PROCEDURE
Study participants were assigned to a control or primed condi-
tion based on their day of enrollment. Participants assigned to
the “primed” condition were exposed to Lipitor (atorvastatin)
branded promotional items immediately prior to completing a
computer-based study instrument. These exposures included Lipi-
tor logos on a clipboard (used when signing in to the study room)
and notepaper (used to provide participants with their study iden-
tification number). Participants assigned to the control condi-
tion completed the same procedures but with a plain (non-
branded) clipboard and notepaper. Randomization was conducted
by day in order to avoid contamination of conditions.
We did not reveal the specific focus of the study to the partici-
pants until the entire study was complete. Participants were told
they were enrolling in a study about clinical decision making un-
der varying conditions. Participants were asked not to discuss the
experimentwithothersuntil theywerenotified that thestudywas
complete.At that time,participantsweredebriefedbye-mailwith
an explanation of the specific aims of the experiment.
OUTCOME MEASURES
Our study was designed to measure the influence of exposure
to branded promotional items on relative attitudes toward 2
lipid-lowering statins. We examined differences in attitudes to-
ward Lipitor and Zocor (simvastatin) in our exposed (Lipitor
promotional items) and control groups. Lipitor is among the
most promoted brand-name statins in the United States while
simvastatin is available generically and considered to be nearly
equally effective. The study outcomes included measures of im-
plicit and self-reported (ie, explicit) attitudes.
Implicit attitudes were evaluated with the Implicit Associa-
tion Test,11-15 a widely used tool in marketing and psychology re-
search that is thought to be resistant to social desirability bias
among research participants. Initial applications of the IAT, for
example, demonstrated the persistence of racial and gender ste-
reotypes and prejudices, even in the face of strong conscious be-
liefs that such attitudes do not exist and strong social norms that
dictate they should not exist.16,17 Results from the IAT are a bet-
ter predictor of intergroup discrimination (eg, biased behavior
against people of other races/ethnicities, gender, and sexual ori-
entation based on existing attitudes and stereotypes) compared
with ostensibly similar self-report measures.13 In recent years, the
use of the IAT has been expanded to research focused on brand-
ing and marketing.18,19 Further details regarding application and
validity of the IAT have been published elsewhere13-15; a demon-
stration can be found at the Project Implicit Web site (https:
//implicit.harvard.edu/implicit).
Conceptually, the IAT pairs targets (eg,Lipitor andZocor) with
attributes (eg, pleasantor unpleasant) and requires subjects to sort
corresponding images and words. Differences in reaction times
when pairing targets and attributes are a clue to implicit atti-
tudes. For example, greater speed when Lipitor and pleasant are
paired or when Zocor and unpleasant are paired reflects a more
favorable attitude toward Lipitor than Zocor. The IAT in this study
comprised 5 related categorization tasks performed on a com-
puter. In tasks 1 and 2, study participants learn the appropriate
behavioral response (usually a key press) for each of 4 catego-
ries: 2 categories that represent the target objects (Lipitor andZo-
cor) and two categories that represent the attributes (pleasant and
unpleasant). In these initial tasks, words or images representing
the target objects and attributes were presented, and partici-
pants were prompted to quickly and accurately assign each word
or image to the appropriate category using assigned computer keys.
Following those tasks, the participants completed an initial com-
bined task in which 1 attribute and 1 target object category (eg,
pleasant and Lipitor) are assigned to 1 response button, while the
other attribute and target object categories (eg, unpleasant andZo-
cor) are assigned to the other. Study participants were again in-
structed to quickly and accurately assign the items to the appro-
priate response key. Following a fourth categorization that reverses
the key assignments for the target categories, study participants
then complete a final reversed combined task requiring the cat-
egorization of pleasant and Zocor on the same key, and unpleas-
ant andLipitor on the other key. During each task, response times
were recorded.
Explicit attitudes were assessed by self-report. Following the
IAT, participants were asked to compare Lipitor and Zocor in
5 dimensions (superiority, preference, efficacy, safety, and con-
venience) using an 11-point scale (Lipitor Strongly Pre-
ferred=5, Zocor Strongly Preferred=−5).
Study participants were contacted by e-mail after comple-
tion of the first phase of the study with a follow-up anony-
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mous Internet-based survey that assessed their attitudes to-
ward pharmaceutical marketing. The purpose was to measure
differences in attitudes among students at the 2 schools given
the differing institutional policies as a possible explanatory fac-
tor. Participants completed a 9-item previously published in-
strument with a 4-point scale that assessed their level of agree-
ment with statements measuring their acceptance of and
skepticism regarding pharmaceutical marketing.20
STATISTICAL ANALYSIS
The primary outcome measure, the mean IAT effect, was
calculated by dividing differences in average response times
when the 2 drugs are paired with different attributes by the
pooled standard deviation as described in previously pub-
lished research.21 Comparisons of the IAT effect across ex-
posed and control groups were performed using indepen-
dent-sample t tests. Results were stratified by school and
class year to account for institutional and training-year ef-
fects. Analysis of variance (ANOVA) was used to calculate
the interaction effect for school, class year, and experimen-
tal exposure. Explicit attitude measures that compared Lipi-
tor and Zocor were combined into a Lipitor preference scale
with a range of −5 to5, with positive values reflecting a
Lipitor preference. Nonparametric tests (Mann-Whitney
tests) were used to compare means from the Lipitor pref-
erence scale across groups. Chi-squared statistics were used
to compare proportions of subjects in agreement with at-
titude statements in our follow-up pharmaceutical mar-
keting survey. We collapsed the 9 items from the survey
into a 6-item scale (range, 0-1) as a measure of skepticism
toward pharmaceutical marketing. The items (1, 5-9) were
selected based on the previously published 8-school
survey to allow for a direct comparison with our results.20
All P values computed were 2-sided. All analyses were per-
formed using the Stata software program, version 9.2
(StataCorp LP; College Station, Texas).
RESULTS
A total of 352 third- (n=191) and fourth-year (n=161)
medical students participated in our study. The demo-
graphic characteristics of the participants are summa-
rized in Table 1. At Miami, 198 students were enrolled
from a potential pool of 324 third- and fourth-year stu-
dents. At Penn, 154 students were enrolled from a po-
tential pool of 410 third- and fourth-year students. The
average age of participants was 25.7, with similar num-
bers of men and women. There were no significant dif-
ferences in demographic characteristics by experimen-
tal group except for training year. Fourth-year students
were represented in greater numbers in the control group,
as were third-year students in the exposed group.
IMPLICIT ATTITUDES
The results from the IAT are presented in Table 2 strati-
fied by school and class year. Overall, students in both class
years at both schools demonstrated implicit attitudes fa-
voring Lipitor over Zocor as reflected by the positive val-
ues even among control students. However, there were sig-
nificant differences between the exposed and control groups
among fourth-year medical students at Penn and Miami.
At Miami, fourth-year students exposed to Lipitor promo-
tional items demonstrated stronger preferences toward Lipi-
tor compared to the control group (P=.05), a finding that
supports our first hypothesis. In contrast, Penn fourth-
year students exposed to Lipitor-branded items exhibited
the opposite response, demonstrating weaker preferences
toward Lipitor compared to the control group (P=.002).
There were no significant experimental effects noted among
third-year medical students at either Penn or Miami (P=.87
andP=.44, respectively). This interaction effect of our mar-
keting exposure with school and class year is depicted in
the Figure (P=.003).
EXPLICIT ATTITUDES
The explicit attitude Lipitor preference scale that com-
pares Lipitor with Zocor had high internal reliability
(Cronbach =0.80). Subjects demonstrated a prefer-
ence toward Lipitor compared to Zocor independent of
our intervention (Table 3). We did not observe a sig-
nificant experimental effect across the 2 groups overall
or within school–class-year strata. These results suggest
that, when students self-report their explicit prefer-
ences, they have a slight preference for Lipitor but re-
veal no effects from a brief exposure to branded promo-
tional items.
Table 1. Demographic Characteristics of Study Participants
Characteristics
No. (%) of Subjects
P ValueaControl Exposed
Sex
.39
Female 91 (46.2) 88 (53.8)
Male 80 (50.8) 93 (49.2)
Age, y (SD) 25.8 (3.0) 25.5 (2.4) .31
School
.49
University of Pennsylvania (n=154) 78 (50.7) 76 (49.3)
University of Miami (n=198) 93 (47.0) 105 (53.0)
Training year
.001
Third-year medical student (n=191) 69 (36.1) 122 (63.9)
Fourth-year medical student (n=161) 102 (63.4) 59 (36.7)
aP value from a 2 test for dichotomous variables and t test for continuous variables.
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ATTITUDES TOWARD PHARMACEUTICAL
MARKETING BY SCHOOL
Of the 352 study participants, 187 (53.1%) completed
the follow-up anonymous survey assessing attitudes to-
ward pharmaceutical marketing (Table 4). Previously
published results from a 2005 survey20 involving third-
year medical students from 8 schools are included for com-
parison. Neither Penn nor Miami students were in-
cluded in this previous survey. Overall, Penn students
had less favorable attitudes toward pharmaceutical mar-
keting compared to Miami students. For example, 63.3%
of students at Penn agreed that gifts and food from phar-
maceutical sales representatives would influence their
eventual prescribing in contrast to just 29.4% at Miami
(P .001). Two-thirds (66.7%) of students at Penn agreed
that the school should exclude sales representatives from
meeting with students in comparison to just 17.5% at Mi-
ami (P .001). Notably, attitudes of Miami students were
similar to those from the 2005 survey involving 8 schools.
The pharmaceutical marketing skepticism scale had
high internal reliability (Cronbach =0.72). University
Penn students held more skeptical views toward phar-
maceutical marketing compared to Miami students (0.55
vs 0.42, P .001). Miami students held similar views as
students in the previously published survey involving 8
schools (0.42 vs 0.43, P=.53), while Penn students were
more skeptical toward marketing (0.55 vs 0.43, P .001).
COMMENT
Our study finds that subtle exposures to branded phar-
maceutical promotional items influences implicit atti-
tudes of medical students toward pharmaceutical brands.
The observed effect was modified by training year and
school. Among third-year medical students, no signifi-
cant experimental effects were observed. However, among
fourth-year medical students there were significant ef-
fects at both schools in our study. Students at Miami re-
sponded as we hypothesized, shifting their preferences
in the direction of the branding exposure (ie, Lipitor).
However, students at Penn had a boomerang response,
ie, a behavioral response opposite of the implied mar-
keting intent.22 The most likely explanation for the dif-
ference across class year is that, as students advance in
their training, they begin to form attitudes toward vari-
ous treatment options that can be primed with branded
promotional items. In comparison to third-year stu-
dents, fourth-year students have had greater clinical ex-
Table 2. Effect of Exposure to Promotional Items on Lipitor Preference—Implicit Attitude Measures (IAT Effect)a
Control Exposed Branding Effectb P Valuec
University of Pennsylvania medical students 0.51 0.37 −0.14 .03d
Third-year students 0.51 0.49 −0.02 .87
Fourth-year students 0.52 0.22 −0.30 .002e
University of Miami medical students 0.49 0.51 0.02 .74
Third-year students 0.53 0.47 −0.06 .44
Fourth-year students 0.47 0.66 0.19 .05d
All medical students 0.50 0.45 −0.05 .27
aThe Implicit Association Test (IAT) effect represents the difference in average IAT response times when Lipitor is paired with positive or negative attributes
divided by the pooled standard deviation.21 Larger positive numbers reflect a stronger Lipitor preference.
bBranding effect represents the difference in IAT effect between experimental groups. Positive numbers indicate an experimental effect that increased the
preference for Lipitor.
cStatistical significance denoted.
dP .05.
eP .01.
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Figure. Lipitor preference among third- and fourth-year medical students in
exposed and control groups, as measured by the Implicit Association Test
(IAT). Higher IAT values reflect a stronger Lipitor preference relative to
Zocor. The interaction effect for experimental group with school and class
year is significant (P=.003). Penn indicates students at the University of
Pennsylvania School of Medicine; Miami, students at the University of
Miami, Miller School of Medicine
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perience and greater exposure to their clinical teachers
and prevailing institutional practices.
The divergent effects at our 2 study schools are an in-
teresting finding. At Penn, exposure to the branded items
produced less favorable implicit attitudes. One potential
explanation for this effect is that the strong school policy
provided an external warning about specific persuasion tac-
tics underlying pharmaceutical marketing. This informa-
tion may have motivated some form of resistance by the
audience23 that could have taken the form of simple mes-
sage rejection or active counterarguing or careful message
scrutiny.24 The policy therefore may have heightened the
ability of the Penn students to exercise what has been termed
“persuasion coping effectiveness”,25 which produces a goal
within oneself to achieve one’s own current learning or at-
titudinal goal independently of what the marketer seems
to be trying to accomplish. The differential attitudes ob-
served in the marketing survey, with the Penn students ex-
hibiting significantly more negative attitudes than those in
the national sample or for the Miami students where no
policy exists, support this explanation. At Miami, where
students had more positive attitudes toward marketing, ex-
posure to a branded promotional item likely primed more
positive implicit associations.
Table 3. Self-Reported (Explicit) Attitudes—Lipitor Preference Scalea
Mean Scaled Responses
Control Exposed Difference P Value
University of Pennsylvania medical students 0.47 0.37 0.10 .10
Third-year students 0.49 0.43 0.06 .44
Fourth-year students 0.45 0.31 0.14 .12
University of Miami medical students 0.79 0.67 0.12 .37
Third-year students 0.79 0.63 0.16 .57
Fourth-year students 0.79 0.80 −0.01 .95
All study participants 0.64 0.55 0.10 .13
aScale with a range of −5 to 5, with positive numbers indicating Lipitor preference and negative numbers indicating Zocor preference.
Table 4. Attitudes About Pharmaceutical Marketing by Medical School
Penn
(n=90)
Miami
(n=97)
2005
National
Surveya
P Value
(Penn vs
Miami)
P Value
(Penn vs
National
Survey)
P Value
(Miami vs
National
Survey)
% in Agreement
Most grand rounds sponsored by drug companies
are helpful and educational
52.2 85.6 89.0 .001c .001c .32
It is sometimes okay for students to accept gifts
and lunches from drug companies because most
students have considerable debts and minimal income
52.2 74.2 80.3 .002c .001c .16
Drug company materials are a useful way to learn
about new drugs
53.3 65.0 71.3 .11 .001c .20
It is sometimes okay for students to accept gifts
and lunches from drug companies because drug
companies have minimal influence on students
30.0 60.8 71.1 .001c .001c .04a
Funds to medical schools from drug companies are
a helpful way to lower tuition
44.4 54.6 53.8 .16 .09 .88
My school should exclude pharmaceutical
representatives from meeting with students
and residents
66.7 17.5 17.3 .001c .001c .96
Receiving gifts or food from pharmaceutical
representatives increases the chance that I will
eventually prescribe the drug company’s products
63.3 29.4 31.2 .001c .001c .71
Receiving gifts or food from pharmaceutical
representatives increases the chances that my fellow
students will eventually prescribe the drug
company’s products
68.9 38.2 42.3 .001c .001c .44
Drug company–sponsored grand rounds are often
biased in favor of the company’s products
92.2 67.7 67.4 .001c .001c .95
Mean Scaled Score
Summary pharmaceutical marketing skepticism scaleb 0.55 0.42 0.43 .001c .001c .53
Abbreviations: Penn, University of Pennsylvania School of Medicine; Miami, University of Miami Miller School of Medicine.
aSample size varied by item from 663 to 808.
bHigher numbers reflect increased skepticism about pharmaceutical marketing.
cP .01.
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While the presence or absence of a school policy is a
reasonable explanation for our findings, we cannot prove
causality nor can we exclude other school-level charac-
teristics as alternative explanations. Nonetheless, it is no-
table that the attitudes of Miami students regarding phar-
maceutical marketing are remarkably similar to those
outlined in the 8-school survey20 published in 2005, while
the Penn students hold considerably less favorable atti-
tudes in the context of restrictive policies toward phar-
maceutical marketing.
The lack of significant findings in our explicit atti-
tude measures raises several interesting conclusions and
questions. First, self-reported attitudes are vulnerable to
social desirability bias. If the hypothesized effect of a mar-
keting exposure were positive toward a brand, then we
would expect social desirability to operate in the oppo-
site direction as the experimental effect. This may ac-
count for our null findings among fourth-year students
at Miami on explicit attitude measures in contrast to our
IAT findings. Second, the IAT is likely to be a much more
sensitive measure than explicit attitude measures. Stud-
ies that simply rely on self-reported attitudes may miss
important effects. Novel methods that provide indirect
measures of attitudes are an important addition to the
methods used to study the effects of marketing.
There are some limitations to our experiment. Most
importantly, our findings are focused on attitudes as op-
posed to behaviors. However, effects on attitudes are no-
table given that our exposure was brief and subtle, and
attitudes are known to be a significant predictor of be-
haviors.26 The simulation in the experimental setting of
repeated exposure to promotional items that occurs in
clinical practice would be challenging. However, im-
plicit attitudes have been shown to more directly trans-
late into behaviors under conditions of high cognitive load
such as time pressure, a situation common in clinical prac-
tice.27 Another limitation is that the training year differ-
ences we observed may reflect a cohort effect. Our ran-
domization procedures also did not produce balanced
groups with respect to training year. This is likely due
to the fact it was necessary to randomize by day to avoid
contamination of experimental groups and that class train-
ing schedules may have facilitated participation on cer-
tain days. However, we addressed this imbalance by strati-
fying our analysis by class year. Another possible limitation
to our study is that study subjects could have been aware
of the study hypothesis despite the fact that we did not
directly reveal it. Only our self-reported explicit atti-
tude measures would be vulnerable in this circum-
stance. One of the advantages of the IAT is its resistance
to such demand characteristics, which lends strength to
our findings. Finally, we are unable to draw specific con-
clusions regarding practicing physicians. Our study was
focused on medical students in their third and fourth years
of training, and the generalizability of our findings to prac-
ticing physicians is unknown. These limitations are bal-
anced by significant strengths, including the random-
ized experimental design and novel outcome measures
that are less susceptible to bias.
In conclusion, our study is the first of which we are
aware to experimentally measure the effect of exposure
to small branded pharmaceutical promotional items on
brand preferences among medical students. Our results
provide evidence that subtle branding exposures are im-
portant and influential, as the psychology and market-
ing literature would suggest. Our findings are particu-
larly notable because they are attributable to simple
exposure to promotional items independent of other ef-
fects attributable to the social relationships associated with
gifts. Our study also suggests that institutional policies,
by way of their influence on student attitudes toward mar-
keting, could lead to different responses to branded pro-
motional items.
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